Ultragenyx Pharmaceutical Inc. Common Stock (NASDAQ: RARE) last traded at $15.48, up 1.24% on the session. The quote above updates while this page is open; the figures below are drawn from Ultragenyx Pharmaceutical Inc. Common Stock’s own filings and are restated only when a new one is published.
Ultragenyx Pharmaceutical Inc. Common Stock trades on NASDAQ under the ticker RARE. Its market capitalisation is $1.53 billion.
Valuation measures for Ultragenyx Pharmaceutical Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $1.53B |
|---|---|
| Enterprise value | $2.95B |
| Price / sales | 2.13 |
| Beta | 1.27 |
Trailing-twelve-month figures tagged in Ultragenyx Pharmaceutical Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) |
|---|
| $716.71M |
| Net income (TTM) | -$586.00M |
|---|
| EPS (TTM) | -$5.83 |
|---|
| Operating margin | -73.67% |
|---|
| Cash | $125.00M |
|---|
Range and volume for RARE over the past 52 weeks.
| 52-week high | $39.89 |
|---|---|
| 52-week low | $12.73 |
| Volume | 2.93M |
| Average volume | 3.85M |
| Previous close | $15.29 |
Invest a chosen dollar amount in Ultragenyx Pharmaceutical Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell RARE.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.